K Charles Janac Sells 17,856 Shares of Arteris, Inc. (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIP) CEO K Charles Janac sold 17,856 shares of Arteris stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $10.12, for a total transaction of $180,702.72. Following the completion of the transaction, the chief executive officer now owns 10,287,435 shares in the company, valued at $104,108,842.20. This trade represents a 0.17 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

K Charles Janac also recently made the following trade(s):

• On Tuesday, December 3rd, K Charles Janac sold 1,242 shares of Arteris stock. The shares were sold at an average price of $8.58, for a total value of $10,656.36.
• On Wednesday, October 2nd, K Charles Janac sold 5,520 shares of Arteris stock. The shares were sold at an average price of $7.18, for a total value of $39,633.60.

Arteris Trading Up 1.5 %

Shares of Arteris stock opened at $10.29 on Friday. The company’s fifty day moving average price is $8.00 and its two-hundred day moving average price is $7.83. The firm has a market capitalization of $413.45 million, a PE ratio of -10.72 and a beta of 1.25. Arteris, Inc. has a 52-week low of $4.83 and a 52-week high of $10.60. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16.

Analysts Set New Price Targets

Separately, Rosenblatt Securities reiterated a “buy” rating and set a $15.00 price target on shares of Arteris in a report on Wednesday, November 6th.

Institutional Trading of Arteris

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. US Bancorp DE acquired a new stake in Arteris during the 3rd quarter valued at $34,000. The Manufacturers Life Insurance Company bought a new stake in shares of Arteris during the second quarter worth $86,000. Algert Global LLC acquired a new stake in shares of Arteris in the second quarter valued at $115,000. MetLife Investment Management LLC raised its holdings in shares of Arteris by 129.1% in the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock valued at $131,000 after buying an additional 9,551 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd bought a new position in shares of Arteris in the third quarter valued at about $226,000. Institutional investors own 64.36% of the company’s stock.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.